{
  "cg:id": "CritAssess012",
  "cg:type": "CriterionAssessment",
  "criterion": {
    "cg:id": "PS3",
    "cg:type": "Criterion",
    "description": "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product",
    "shortDescription": "well-established damaging effect functional studies",
    "defaultOutcome": "CG:S",
    "targetInterpretation": "LN:LA6668-3"
  },
  "variant": {
    "cg:id": "CanAll020",
    "cg:type": "CanonicalAllele",
    "preferredCtxAllele": "CtxAll023",
    "identifier": "http://reg.genome.network/allele/CA220161"
  },
  "outcome": "CG:S",
  "wasGeneratedBy": {
    "cg:id": "AssessCrit012",
    "cg:type": "AssessCriterion",
    "startedAtTime": "2016-06-04T07:12:00+00:00",
    "endedAtTime": "2016-06-04T07:12:00+00:00",
    "wasAssociatedWith": [
      {
        "cg:id": "Agent001",
        "cg:type": "Agent",
        "description": "SH",
        "name": "Steven Harrison"
      },
      {
        "cg:id": "Agent004",
        "cg:type": "Agent",
        "description": "NWG",
        "name": "Noonan/Rasopathy WG (ClinGen)"
      }
    ],
    "used": {
      "Data": [
        {
          "cg:id": "Func026",
          "cg:type": "FunctionalData",
          "result": "abnormal/deceased MEK activtation.",
          "dataType": "CG:activation",
          "contextualAllele": {
            "cg:id": "CtxAll024",
            "cg:type": "ContextualAllele",
            "relatedCanonicalAllele": {
              "cg:id": "CanAll021",
              "cg:type": "CanonicalAllele",
              "preferredCtxAllele": "CtxAll024",
              "identifier": "http://reg.genome.network/allele/CA093846"
            },
            "alleleName": "NP_004324.2:p.Gly596Val"
          },
          "gene": {
            "cg:id": "G014",
            "cg:type": "Gene",
            "symbol": "MEK"
          }
        },
        {
          "cg:id": "Func027",
          "cg:type": "FunctionalData",
          "result": "abnormal/deceased ERK activtation.",
          "dataType": "CG:activation",
          "contextualAllele": {
            "cg:id": "CtxAll024",
            "cg:type": "ContextualAllele",
            "relatedCanonicalAllele": {
              "cg:id": "CanAll021",
              "cg:type": "CanonicalAllele",
              "preferredCtxAllele": "CtxAll024",
              "identifier": "http://reg.genome.network/allele/CA093846"
            },
            "alleleName": "NP_004324.2:p.Gly596Val"
          },
          "gene": {
            "cg:id": "G015",
            "cg:type": "Gene",
            "symbol": "ERK"
          }
        }
      ],
      "Criterion": [
        {
          "cg:id": "PS3",
          "cg:type": "Criterion",
          "description": "Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product",
          "shortDescription": "well-established damaging effect functional studies",
          "defaultOutcome": "CG:S",
          "targetInterpretation": "LN:LA6668-3"
        }
      ],
      "CanonicalAllele": [
        {
          "cg:id": "CanAll020",
          "cg:type": "CanonicalAllele",
          "preferredCtxAllele": "CtxAll023",
          "identifier": "http://reg.genome.network/allele/CA220161"
        }
      ]
    }
  },
  "explanation": "The RASopathy group considers MEK and ERK activation assays as well validated."
}
